(Q44567348)

4 December 2017

Simultaneous determination of losartan and EXP3174 in human plasma and urine utilizing liquid chromatography/tandem mass spectrometry (English)

1 reference

liquid chromatography-tandem mass spectrometry

4 December 2017

1 reference

1 reference

Michelle Polinko

1

1 reference

4 December 2017

Kerry Riffel

series ordinal

2

1 reference

4 December 2017

Hengchang Song

series ordinal

3

1 reference

4 December 2017

Man-Wai Lo

series ordinal

4

1 reference

4 December 2017

1 September 2003

1 reference

4 December 2017

12

1 reference

Journal of Pharmaceutical and Biomedical Analysis

inferred from page(s)

published in

1 reference

4 December 2017

33

1 reference

4 December 2017

1

1 reference

4 December 2017

73-84

1 reference

A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900348-0

7 January 2021

Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900348-0

7 January 2021

Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900348-0

7 January 2021

HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900348-0

7 January 2021

Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900348-0

7 January 2021

An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900348-0

7 January 2021

Experimental design methodologies to optimise the spectrofluorimetric determination of Losartan and Valsartan in human urine.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900348-0

7 January 2021

Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900348-0

7 January 2021

Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900348-0

7 January 2021

Method for the simultaneous determination of losartan and its major metabolite, EXP-3174, in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900348-0

7 January 2021

Quantitation of SR 27417 in human plasma using electrospray liquid chromatography-tandem mass spectrometry: A study of ion suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900348-0

7 January 2021

Effect of the sample matrix on the determination of indinavir in human urine by HPLC with turbo ion spray tandem mass spectrometric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900348-0

7 January 2021

Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900348-0

7 January 2021

10.1016/S0731-7085(03)00348-0

Identifiers

DOI

1 reference

4 December 2017

1 reference